The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.
January 3rd 2025
A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension (PAH).
December 30th 2024
Macitentan Safety, Effectiveness in PAH Confirmed in New Analysis
Potential Risk Factors Identified for RRT Among Patients With PH
Potential for Precision Medicine Approach in PAH Explored in New Study